Home GLP-1's New Battlefield: Hengrui's HRS-7535 Enters Phase III for Chronic Kidney Disease

GLP-1's New Battlefield: Hengrui's HRS-7535 Enters Phase III for Chronic Kidney Disease

Jun 09, 2026 12:00 CST Updated 14:25
Hengrui Pharma

Innovative and High-Quality Pharmaceutical Developer